Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients

Radiotherapy and Oncology

Volumn 92, Issue 2, 2009, Pages 202-209

  Nijkamp, Jasper ^a   de Jong, Rianne ^a   Sonke, Jan Jakob ^a   Remeijer, Peter ^a   van Vliet, Corine ^a   Marijnen, Corrie ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Cone beam CT; CTV shape variation; Intra fraction setup errors; Margins; Rectal cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY; DOSIMETRY; DRUG TARGETING; EVALUATION; HUMAN; IMAGING AND DISPLAY; OUTCOME ASSESSMENT; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RECTUM CANCER; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RECTAL NEOPLASMS; RECTUM; URINARY BLADDER;

EID: 67650954457     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.04.022     Document Type: Article

References (25)

1. Martling A.L., Holm T., Rutqvist L.E., et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 356 (2000) 93-96
2. Wibe A., Moller B., Norstein J., et al. A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 45 (2002) 857-866
3. Kapiteijn E., Putter H., and van de Velde C.J. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 89 (2002) 1142-1149
4. Heald R.J., and Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1 (1986) 1479-1482
5. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997;336:980-7.
6. Peeters K., Marijnen C., Nagtegaal I., et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246 (2007) 693-701
7. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 35 (2004) 1731-1740
8. Sebag-Montefiore D., Stephens R.J., Steele R., et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373 (2009) 811-820
9. Minsky B., Conti J., Huang Y., et al. Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 13 (1995) 1409-1416
10. Letschert J., Lebesque J., de Boer R., et al. Dose-volume correlation in radiation-related late small-bowel complications: a clinical study. Radiother Oncol 18 (1990) 307-320
11. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
12. Urbano M., Henrys A., Adams E., et al. Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high doses. Int J Radiat Oncol Biol Phys 26 (2006) 907-916
13. Rasch C., Steenbakkers R., and van Herk M. Target definition in prostate, head, and neck. Semin Radiat Oncol 15 (2005) 136-145
14. Arcangeli S., Valentini V.V., Nori S.L., et al. Underlying anatomy for CTV contouring and lymphatic drainage in rectal cancer radiation therapy. Rays 28 (2003) 331-336
15. Höcht S., Hammad R., Thiel H., et al. Recurrent rectal cancer within the pelvis. A multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy. Strahlenther Onkol 180 (2004) 15-20
16. Roels S., Duthoy W., Hausermans K., et al. Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 65 (2006) 1129-1142
17. Nuyttens J., Robertson J., Yan D., et al. The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. Int J Radiat Oncol Biol Phys 53 (2002) 497-503
18. Tournel K., de Ridder M., Engels B., et al. Assessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computer tomography. Int J Radiat Oncol Biol Phys 71 (2008) 934-939
19. Hoogeman M.S., van Herk M., de Bois J., et al. Quantification of local rectal wall displacements by virtual rectum unfolding. Radiother Oncol 70 (2004) 21-30
20. Tucker S.L., Dong L., Cheung R., et al. Comparison of rectal dose-wall histogram versus dose-volume histogram for modelingthe incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 1589-1601
21. Xu F., Wang J., Sen B., et al. Detection of intrafractional tumour position error in radiotherapy utilizing cone beam computed tomography. Radiother Oncol 89 (2009) 311-319
22. O'Doherty U.M., McNair H.A., Norman A.R., et al. Variability of bladder filling in patients receiving radical radiotherapy to the prostate. Radiother Oncol 79 (2006) 335-340
23. van de Bunt L., Jurgerliemk-Schulz I.M., de Kort G.A.P., et al. Motion and deformation of the target volumes during IMRT for cervical cancer: what margins do we need?. Radiother Oncol 88 (2008) 233-240
24. Smitsmans M.H., Pos F.J., de Bois J., et al. The influence of a dietary protocol on cone beam CT-guided radiotherapy for prostate cancer patients. Int J Radiat Oncol Biol Phys 71 (2008) 1279-1286
25. van Herk M., Remeijer P., Rasch C., et al. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 1121-1135